Latest News and Press Releases

HIFIVE is a Phase I trial to assess the safety and performance of Sonablate high-intensity focused ultrasound for treating incompetent veins

LOUISVILLE, Ky., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Norton Neuroscience Institute is the first and only facility in Kentucky to offer MRI-guided high-frequency focused ultrasound for essential...

Charlottesville, Virginia, Oct. 24, 2019 (GLOBE NEWSWIRE) -- The Focused Ultrasound Foundation is pleased to announce that Narendra (Naren) Sanghvi, PhD, has joined the team in the newly created...

LAWRENCEVILLE, N.J., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that on February 19, 2019, the Compensation Committee...

LAWRENCEVILLE, N.J., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that Jeffrey Church, Celsion’s Executive Vice...

Publication Highlights Phase I Data Supporting Safety and Feasibility of Treatment with ThermoDox® and Non-Invasive, Focused Ultrasound University of Oxford’s Findings Provide Additional...

Charlottesville, VA, Oct. 18, 2018 (GLOBE NEWSWIRE) -- WHAT: A briefing featuring key data presented at the 6th International Symposium on Focused Ultrasound, the world's leading forum dedicated to...

CHARLOTTE, N.C., May 10, 2017 (GLOBE NEWSWIRE) -- HIFU Prostate Services, LLC (HPS), the leading provider of HIFU technology to physician’s practices in the United States, reflects on a year of...

LOS ANGELES, Calif., July 05, 2016 (GLOBE NEWSWIRE) -- Western States HIFU, in partnership with HIFU Prostate Services, the first and most experienced company to provide HIFU treatment for prostate...